Niagen Bioscience, Inc.
NAGE
$6.53
$0.132.03%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 20.43M | 17.73M | 14.11M | 8.55M | 1.49M |
| Total Depreciation and Amortization | 944.00K | 951.00K | 962.00K | 983.00K | 998.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -449.00K | -1.46M | -1.83M | -558.00K | 4.58M |
| Change in Net Operating Assets | 484.00K | 3.99M | 6.46M | 3.13M | -2.89M |
| Cash from Operations | 21.41M | 21.21M | 19.70M | 12.11M | 4.18M |
| Capital Expenditure | -260.00K | -277.00K | -154.00K | -163.00K | -115.00K |
| Sale of Property, Plant, and Equipment | 0.00 | 20.00K | 20.00K | 20.00K | 20.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -260.00K | -257.00K | -134.00K | -143.00K | -95.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -12.00K | -12.00K | -11.00K | -11.00K | -10.00K |
| Issuance of Common Stock | 10.81M | 11.70M | 8.55M | 5.43M | 1.64M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -53.00K | -53.00K | -47.00K | -52.00K | -86.00K |
| Cash from Financing | 10.74M | 11.64M | 8.49M | 5.37M | 1.55M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 31.89M | 32.59M | 28.05M | 17.34M | 5.63M |